Endodontic Treatment Using CTZ Paste in Primary Teeth (SLM2204)

December 21, 2018 updated by: Jose Carlos P Imparato, Faculty Sao Leopoldo Mandic Campinas

Efficacy of Endodontic Treatment Using CTZ Paste in Primary Teeth: Randomized Clinical Trial

The aim of this study is to evaluate the efficacy of CTZ Paste in primary teeth, compared to endodontic treatment with Guedes-Pinto Paste. This is a multicenter, randomized, double-blind (patient), controlled and non-inferiority clinical study on 174 primary molars and 174 primary incisors of 3-6 years-old children with carious lesions with pulp involvement. The sample unit will be the tooth, which will be randomized into two groups. The teeth allocated to the experimental group will be treated with CTZ Paste, whereas the treatment of those teeth allocated to the control group will employ the Guedes-Pinto Paste. The procedures performed will be evaluated clinically and radiographically at 6 and 12 months. Secondary outcomes such as cost, discomfort, satisfaction and quality of life will also be evaluated.

Study Overview

Status

Unknown

Conditions

Study Type

Interventional

Enrollment (Anticipated)

174

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • SP
      • Campinas, SP, Brazil, 13045-755
        • Recruiting
        • Faculdade Sao Leopoldo Mandic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years to 6 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • children aged from 3 to 6 years and 11 months;
  • children present at least one upper or lower molar or primary upper incisor with untreated carious lesion with pulp envelopment;
  • children assent to participate in the study through collaborative behavior;
  • children's parents/guardians consent to their participation by signing the Informed Consent Form (ICF).

Exclusion Criteria:

  • tooth with carious lesion involving three or more dental surfaces, making the restoration extremely difficult or impossible;
  • tooth with internal or external resorption in more than 1/3 of the root length;
  • tooth whose crypt of the successor permanent is affected;
  • tooth which have less than 2/3 of the root;
  • patients who present health problems with oral impairment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: CTZ Paste
Endodontic treatment with CTZ paste.
Tooth allocated to this group will be treated with CTZ paste, according to the Cappielo's protocol (1964), updated by Moura et al. (2016).
Experimental: GP Paste
Endodontic treatment with Guedes-Pinto paste.
Tooth allocated to this group will be treated with Guedes-Pinto paste, according to the Guedes-Pinto's protocol (1981), updated by Mello-Moura et al. (2011).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical and radiographical efficacy of the endodontic treatment
Time Frame: 12 Months
The tooth will be evaluated according to the presence of mobility (yes or no) and regarding radiolucency area on initial and final radiography (measured and compared with the program ImageJ).
12 Months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cost-efficacy
Time Frame: Through study completion (12 months)
The costs of each treatment procedure will be calculated and compared with thresholds values for intervention cost-effectiveness by region, determined by World Health Organization (http://www.who.int/choice/costs/CER_levels/en/). These values will be combined with the evaluated efficacy of the treatments (according description of Outcome 1).
Through study completion (12 months)
Children's satisfaction with treatment
Time Frame: Through study completion (12 months)
The satisfaction of each treatment will be evaluated using the Wong-Baker Facial Scale (Wong & Baker, 1988). The patient will be asked to choose the face that is more similar to how he/she felt during the treatment. The answer should be given solely by the child, which means no parental or professional interferences.
Through study completion (12 months)
Parents/Guardians' satisfaction with children's treatment
Time Frame: Through study completion (12 months)
The parents' satisfaction with each treatment will be evaluated using the Parent's Questionnaire about Teeth Appearance (Furtado et al., 2012).
Through study completion (12 months)
Impact of treatment on children's quality of life
Time Frame: Baseline and 12 months
The oral health related quality of life will be measured using a validated questionnaire according to the children's age. The "Early Childhood Oral Health Impact Scale" (ECOHIS) (Tesch et al., 2008) will be applied with 4-5 years old patients. The "Child Perceptions Questionnaire" (CPQ) will be used for 6-9 years old patients (Martins et al., 2009). The same questionnaire will be applied immediately before the procedure and on 12 months follow-up. Only one type of questionnaire will be used with each child, according to its age.
Baseline and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2017

Primary Completion (Actual)

December 1, 2018

Study Completion (Anticipated)

December 1, 2019

Study Registration Dates

First Submitted

October 25, 2018

First Submitted That Met QC Criteria

November 5, 2018

First Posted (Actual)

November 6, 2018

Study Record Updates

Last Update Posted (Actual)

December 24, 2018

Last Update Submitted That Met QC Criteria

December 21, 2018

Last Verified

December 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • SLM4

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pulpectomy Agents

Clinical Trials on CTZ Paste

3
Subscribe